Financials data is unavailable for this security.
View more
Year on year Johnson & Johnson grew revenues 6.46% from 79.99bn to 85.16bn while net income improved 95.94% from 17.94bn to 35.15bn.
Gross margin | 69.57% |
---|---|
Net profit margin | 19.93% |
Operating margin | 23.42% |
Return on assets | 9.28% |
---|---|
Return on equity | 24.23% |
Return on investment | 13.19% |
More ▼
Cash flow in USDView more
In 2023, Johnson & Johnson increased its cash reserves by 54.73%, or 7.73bn. The company earned 22.79bn from its operations for a Cash Flow Margin of 26.76%. In addition the company generated 878.00m cash from investing, though they paid out 15.83bn more in financing than they received.
Cash flow per share | 9.66 |
---|---|
Price/Cash flow per share | 14.83 |
Book value per share | 29.09 |
---|---|
Tangible book value per share | -0.3665 |
More ▼
Balance sheet in USDView more
Current ratio | 1.17 |
---|---|
Quick ratio | 0.9363 |
Total debt/total equity | 0.4803 |
---|---|
Total debt/total capital | 0.3245 |
More ▼
Growth rates in USD
Growth rate information is not available.
Div yield(5 year avg) | 2.61% |
---|---|
Div growth rate (5 year) | 5.83% |
Payout ratio (TTM) | 66.90% |
EPS growth(5 years) | -1.47 |
---|---|
EPS (TTM) vs TTM 1 year ago | 69.00 |
More ▼